Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism

BACKGROUND: Lowering the dose of desoxycorticosterone pivalate (DOCP) for the treatment of dogs with primary hypoadrenocorticism (PH) decreases costs and could lead to increased owner motivation to treat their affected dogs. OBJECTIVE: To evaluate the efficacy of a low‐dose DOCP treatment protocol i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Vet Intern Med
Autors principals: Sieber‐Ruckstuhl, Nadia S., Reusch, Claudia E., Hofer‐Inteeworn, Nathalie, Kuemmerle‐Fraune, Claudia, Müller, Claudia, Hofmann‐Lehmann, Regina, Boretti, Felicitas S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
SMALL ANIMAL
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524388/
https://ncbi.nlm.nih.gov/pubmed/30865322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15475
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars